Cargando…
Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer
Small-cell lung cancer (SCLC) is a highly malignant type of lung cancer with no effective second-line chemotherapy drugs. Arsenic trioxide (As(2)O(3)) was reported to exert antiangiogenesis activities against lung cancer and induce poor development of vessel structures, similar to the effect observe...
Autores principales: | Yang, Meng-Hang, Chang, Ke-Jie, Li, Bing, Chen, Wan-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481139/ https://www.ncbi.nlm.nih.gov/pubmed/31093499 http://dx.doi.org/10.1155/2019/4647252 |
Ejemplares similares
-
Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade
por: Chang, Ke-Jie, et al.
Publicado: (2020) -
Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling
por: Zheng, Jin-Cheng, et al.
Publicado: (2019) -
Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres
por: Ding, Dacheng, et al.
Publicado: (2014) -
Arsenic Trioxide Inhibits Cell Growth and Induces Apoptosis through Inactivation of Notch Signaling Pathway in Breast Cancer
por: Xia, Jun, et al.
Publicado: (2012) -
Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
por: Hu, Jiasheng, et al.
Publicado: (2013)